Two Sigma Advisers’s BIO-REFERENCE LABS INC-NEW- BRLI Stock Holding History

Two Sigma Advisers’s Portfolio BRLI Stock Details BRLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-48,047	Closed	-$1.98M	–	2162
2015 Q2	$1.98M	Buy	48,047 +22,900	+91%	+$821K	0.01%	807
2015 Q1	$886K	Sell	25,147 -10,100	-29%	-$342K	0.01%	1124
2014 Q4	$1.13M	Buy	+35,247	New	+$1.02M	0.01%	1109
2014 Q3	–	Sell	-7,547	Closed	-$228K	–	2908
2014 Q2	$228K	Buy	+7,547	New	+$208K	﹤0.01%	2206

Other funds holding BRLI

SAM

Shell Asset Management The Hague, Netherlands $996M AUM 26.19% 1-Year Est. Return

Two Sigma Advisers's BRLI Position: Q3 2015 in Review

Two Sigma Advisers sold out of BIO-REFERENCE LABS INC-NEW- (BRLI) in Q3 2015, closing a stake of 48,047 shares — an estimated $1.98M sold.

Two Sigma Advisers first reported a position in BRLI in Q2 2014 and held it in 4 quarters. The position peaked at $1.98M in Q2 2015. 1 fund tracked by Wall St. Rank holds BRLI as of Q3 2015.

Two Sigma Advisers reported no remaining BIO-REFERENCE LABS INC-NEW- position as of Q3 2015 after selling out during the quarter.
Two Sigma Advisers sold 48,047 BIO-REFERENCE LABS INC-NEW- shares in Q3 2015, an estimated $1.98M.
Two Sigma Advisers first reported a position in BIO-REFERENCE LABS INC-NEW- in Q2 2014 and held it in 4 quarters.
Two Sigma Advisers's BIO-REFERENCE LABS INC-NEW- position peaked at $1.98M in Q2 2015.
1 fund tracked by Wall St. Rank held BIO-REFERENCE LABS INC-NEW- as of Q3 2015.

Based on Two Sigma Advisers's 13F filing for Q3 2015, filed 16 Nov 2015.